Slideshow

Quiz: Drug-Induced Parkinsonism

Author(s):

Veronica Hackethal, MD

Does the atypical antipsychotic clozapine carry high risk for the development of drug-induced parkinsonism? What are DSM-5 criteria for the diagnosis of neuroleptic-induced parkinsonism? These questions and more in our quiz.

Related Videos
Fernando L. Pagan, MD
Fernando L. Pagan, MD
Cheryl Kyinn, PA-C
Fernando L. Pagan, MD
Fernando L. Pagan, MD
James Beck, PhD
Fernando L. Pagan, MD
Fernando L. Pagan, MD
Related Content
Gene Therapy AAV-GAD Gains Regenerative Medicine Advanced Therapy Designation as Potential Parkinson Treatment
May 12th 2025

Gene Therapy AAV-GAD Gains Regenerative Medicine Advanced Therapy Designation as Potential Parkinson Treatment

Marco Meglio
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
March 27th 2025

Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care

Marco Meglio
NeurologyLive® Friday 5 — May 9, 2025
May 9th 2025

NeurologyLive® Friday 5 — May 9, 2025

NeurologyLive® Staff
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
January 10th 2025

Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test

Marco Meglio
Parkinson Cell Therapy ANPD001 Generates Promising Early-Stage Phase 1/2 Data
May 7th 2025

Parkinson Cell Therapy ANPD001 Generates Promising Early-Stage Phase 1/2 Data

Marco Meglio
Subthalamic Focused Ultrasound Outperforms Ventral Intermediate Thalamotomy in Sustained Parkinson Disease Tremor Control
May 7th 2025

Subthalamic Focused Ultrasound Outperforms Ventral Intermediate Thalamotomy in Sustained Parkinson Disease Tremor Control

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.